[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Hallal", "age": 58, "title": "CEO & Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 175732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 50, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 704681, "exercisedValue": 0, "unexercisedValue": 3032789}, {"maxAge": 1, "name": "Dr. Akshay K. Vaishnaw M.D., Ph.D.", "age": 61, "title": "President of R&D, Member of Scientific Advisory Board and Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 56140, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 755185, "exercisedValue": 0, "unexercisedValue": 673489}, {"maxAge": 1, "name": "Mr. Vikas  Sinha C.A., CPA, M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Keith Woods", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward H. Myles MBA", "age": 52, "title": "Senior Advisor", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 720786, "exercisedValue": 0, "unexercisedValue": 857292}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 29.7, "open": 29.61, "dayLow": 28.755, "dayHigh": 31.34, "regularMarketPreviousClose": 29.7, "regularMarketOpen": 29.61, "regularMarketDayLow": 28.755, "regularMarketDayHigh": 31.34, "payoutRatio": 0.0, "beta": 0.382, "forwardPE": -14.40465, "volume": 463733, "regularMarketVolume": 463733, "averageVolume": 1210501, "averageVolume10days": 1282650, "averageDailyVolume10Day": 1282650, "bid": 30.82, "ask": 31.28, "bidSize": 1, "askSize": 1, "marketCap": 2937820416, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 32.4468, "twoHundredDayAverage": 28.117775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2439747840, "profitMargins": 0.0, "floatShares": 63191059, "sharesOutstanding": 94860200, "sharesShort": 16971737, "sharesShortPriorMonth": 16131337, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.17889999, "heldPercentInsiders": 0.04344, "heldPercentInstitutions": 1.16285, "shortRatio": 10.81, "shortPercentOfFloat": 0.3166, "impliedSharesOutstanding": 105411000, "bookValue": 3.929, "priceToBook": 7.882413, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -246294000, "trailingEps": -2.47, "forwardEps": -2.15, "enterpriseToEbitda": -9.754, "52WeekChange": 1.0412371, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 30.97, "targetHighPrice": 57.0, "targetLowPrice": 45.0, "targetMeanPrice": 50.5, "targetMedianPrice": 50.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 437278016, "totalCashPerShare": 4.619, "ebitda": -250116992, "totalDebt": 65126000, "quickRatio": 9.362, "currentRatio": 9.612, "debtToEquity": 17.667, "returnOnAssets": -0.40087003, "returnOnEquity": -0.82948, "grossProfits": -184550000, "freeCashflow": -111554872, "operatingCashflow": -200948992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1746724736, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "regularMarketChangePercent": 4.267468, "regularMarketPrice": 30.97, "regularMarketChange": 1.2699986, "regularMarketDayRange": "28.755 - 31.34", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1210501, "fiftyTwoWeekLowChange": 24.21, "fiftyTwoWeekLowChangePercent": 3.5813606, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -16.01, "fiftyTwoWeekHighChangePercent": -0.34078333, "fiftyTwoWeekChangePercent": 104.12371, "earningsTimestamp": 1747225800, "earningsTimestampStart": 1747225800, "earningsTimestampEnd": 1747225800, "earningsCallTimestampStart": 1747224900, "earningsCallTimestampEnd": 1747224900, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.47, "epsForward": -2.15, "epsCurrentYear": -2.62386, "priceEpsCurrentYear": -11.803222, "fiftyDayAverageChange": -1.4768009, "fiftyDayAverageChangePercent": -0.04551453, "twoHundredDayAverageChange": 2.8522243, "twoHundredDayAverageChangePercent": 0.10143848, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]